mortality/aging
• mutants are protected from LPS lethality
|
homeostasis/metabolism
• increase in IL-1beta levels in mesenteric lymph nodes but reduced levels in the lungs after LPS challenge
|
immune system
• increase in IL-1beta levels in mesenteric lymph nodes but reduced levels in the lungs after LPS challenge
|
• mesenteric lymph nodes are 3 times larger than in wild-type 18 hours after LPS challenge
|
• mutants are protected from lipopolysaccharide (LPS) induced lethality
|